Over a month ago |
Options
|
Bearish flow noted in… Bearish flow noted in Ross Stores with 3,269 puts trading, or 1.0x expected. Most active are Feb-23 100 puts and May-23 105 puts, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 1.94, while ATM IV is up over 1 point on the day. Earnings are expected on March 2nd. ShowHide Related Items >><< - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/21/22 Barclays
- Ross Stores price target raised to $127 from $98 at Barclays
- 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 11/18/22
- What You Missed On Wall Street On Friday
- 11/18/22
- What You Missed On Wall Street This Morning
- 11/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/18/22
- Fly Intel: Pre-market Movers
- 11/18/22
- Early notable gainers among liquid option names on November 18th
- 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
|
Recommendations
|
Barclays analyst Adrienne… Barclays analyst Adrienne Yih raised the firm's price target on Ross Stores to $127 from $98 and keeps an Overweight rating on the shares. The company's Q3 earnings report "was the second proof point that the balance of power has shifted in Off-Price's favor," Yih tells investors in a research note. ShowHide Related Items >><< - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- 11/18/22
- What You Missed On Wall Street On Friday
- 11/18/22
- What You Missed On Wall Street This Morning
- 11/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/18/22
- Fly Intel: Pre-market Movers
- 11/18/22
- Early notable gainers among liquid option names on November 18th
- 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
- 05/23/22
- Early notable gainers among liquid option names on May 23rd
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/18/22
- Williams-Sonoma falls -9.7%
- 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 09/14/22
- Williams-Sonoma names Jeff Howie as new CFO
WBA Walgreens Boots Alliance - 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 11/02/22
- Walgreens Boots Alliance agrees to pay $4.95B to settle opioid claims
- 11/02/22
- Walgreens to pay about $5B to resolve some opioid lawsuits with states, tribes
- 11/02/22
- Western Union enters renewed five-year agreement with Walgreens
- 10/14/22
- Spectrum Brands responds to DOJ suit seeking to block sale of HHI segment
- 09/15/22
- Spectrum Brands falls -14.1%
- 09/15/22
- Assa Abloy says 'will vigorously contest' DOJ effort to block deal with Spectrum
- 09/15/22
- Spectrum Brands vows to 'vigorously oppose' DOJ suit on unit sale
- 08/10/22
- SoftBank board approves transfer of Alibaba shares to finance subsidiaries
- 08/09/22
- SoftBank to sell 'some or all of their holdings' in SoFi Technologies
- 06/22/22
- SoftBank Group International Michel Combes to step down, Alex Clavel to succeed
- 06/07/22
- Symbotic completes combination with SPAC SVF Investment
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- $167.51 /
+10.76 (+6.86%) - 11/17/22
- Palo Alto Networks CEO: We're taking a knife to our costs
- 11/17/22
- Palo Alto Networks jumps 5% after Q1 results, FY23 guidance beat estimates
- 11/17/22
- Palo Alto Networks confirms agreement to acquire Cider Security for $195M cash
- 11/17/22
- Palo Alto Networks announces receipt of initial $67M purchase order from DOD
- 11/18/22
- Taylor Swift says 'assured' Ticketmaster could handle ticket demand
- 11/18/22
- Live Nation extends decline, drops 6% to $67.45 after NY Times report
- 11/18/22
- Live Nation drops 3% to $69.57 after NY Times report of DOJ investigation
- 11/17/22
- Ticketmaster confirms public on-sale for Taylor Swift 'Eras Tour' cancelled
- 10/24/22
- Finexio closes $35M Series B funding round
- 10/23/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- Chase, Disney and Visa announce multi-year extension for Disney card programs
- 10/19/22
- Texas AG investigating six banks over consumer protection laws
- 11/16/22
- Else Nutrition launches on second online store, JD.com
- 08/23/22
- JD.com reports annual active customer accounts up 9.2% to 580.8M
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 06/29/22
- JD.com announces renewed strategic cooperation with Tencent
- 11/17/22
- Iveric bio announces FDA granted breakthrough designation for Zimura
- 11/03/22
- Iveric bio submits first part of NDA for rolling review of avacincaptad pegol
- 09/06/22
- Iveric bio says GATHER2 Phase 3 trial met primary endpoint
- 09/02/22
- Iveric bio reports inducement grants under Nasdaq Listing Rule
- 09/01/22
- Avid Technology to replace Plantronics in the S&P 600 at open on 9/1
- 08/30/22
- HP Inc. CEO: Supply chain situation is 'getting closer to normal'
- 08/29/22
- HP Inc. completes acquisition of Poly
- $214.51 /
+0.055 (+0.03%) - 11/18/22
- Honeywell announces $1.325B agreement with asbestos trust
- 11/16/22
- Honeywell announces its technology will support NASA Artemis I launch
- 11/01/22
- Honeywell, Aramco announce JV agreement
- 10/25/22
- Babcock & Wilcox selected for application of CO2 capture solution by Consol
- 11/02/22
- G1 Therapeutics reports data from first patients in Phase 2 study of trilaciclib
- 10/26/22
- G1 announces investigator-initiated study of trilaciclib, lurbinectedin
- 10/10/22
- G1 Therapeutics completes enrollment in Phase 3 clinical trial of trilaciclib
- 09/12/22
- Day One Biopharmaceuticals appoints Nicholson as chairman
- $35.49 /
+19.49 (+121.81%) - 11/18/22
- Grindr completes business combination, to begin trading on NYSE
- 11/17/22
- Gap rises 8% to nearly $14 after Q3 results
- 11/10/22
- Gap launches collection of 'family essentials' with Amazon Fashion
- 10/25/22
- Gap 'taking immediate steps' to remove Yeezy Gap product from stores
- 09/28/22
- Gap unit Athleta teams with thredUP, and Shop Premium Outlets for online
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 11/14/22
- Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes
- 11/14/22
- Google debuts Health Connect beta, supports Peloton, Oura, WeightWatchers apps
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 11/14/22
- Tiger Global takes stakes in Visa, Mastercard, exits position in Flywire
- 11/10/22
- FTC restores rigorous enforcement of law banning unfair methods of competition
- 11/18/22
- Farfetch falls -14.1%
- 11/18/22
- Farfetch falls -12.0%
- 10/21/22
- Farfetch announces first cohort of start-ups for Dream Assembly Base Camp
- 08/29/22
- Farfetch falls -11.9%
- 11/18/22
- Foot Locker rises 14.7%
- 11/18/22
- Foot Locker rises 15.8%
- 11/18/22
- Foot Locker says sustained momentum throughout Q3
- 11/18/22
- Foot Locker jumps 17% to $38.80 after Q3 results beat, FY22 guidance raised
- 11/17/22
- Editas sinks 17% to $10.11 after pausing BRILLIANCE study enrollment
- 11/17/22
- Editas Medicine announces clinical data from Phase 1/2 BRILLIANCE trial
- 10/18/22
- Editas Medicine rises after report of talks to sell preclinical oncology assets
- 10/13/22
- Editas Medicine presents preclinical data on EDIT-103 for RHO-adRP
- 11/18/22
- DraftKings to launch online sportsbook in Maryland on November 23
- 11/09/22
- DraftKings lower after California voters reject sports betting measures
- 11/04/22
- DraftKings CEO: Right in line on where we thought we'd be with user growth
- 10/27/22
- Nevada reports September statewide gaming win up 7.87% to $1.25B
- 11/14/22
- Carvana falls -15.7%
- 11/11/22
- Carvana trading resumes
- 11/11/22
- Carvana trading halted, volatility trading pause
- 11/07/22
- Carvana falls -15.4%
- 11/16/22
- Cathie Wood's ARK Investment bought 245.6K shares of Coinbase today
- 11/16/22
- Coinbase says has 'zero exposure' to Genesis Trading
- 11/11/22
- FTX commences Chapter 11 proceedings, Bankman-Fried resigns
- 11/10/22
- FTX US says trading may be halted 'in a few days'
- 11/17/22
- Ardelyx director Mott acquires 567,000 common shares
- 11/16/22
- Ardelyx trading resumes
- 11/16/22
- Ardelyx's Xphozah for kidney disease receives favorable FDA vote
- 11/16/22
- Nasdaq halts trading of Ardelyx common stock
- $50.45 /
+7.215 (+16.69%) - 11/18/22
- Apellis announces FDA accepts NDA amendment, new PDUFA date for pegcetacoplan
- 11/03/22
- Apellis provides update on intravitreal pegcetacoplan NDA
- 11/03/22
- Apellis to present long-term data on efficacy, safety profile of EMPAVELI
- 09/30/22
- Apellis announces four presentations of data from Phase 3 DERBY, OAKS studies
- $104.70 /
+0.365 (+0.35%) - 11/16/22
- Wafer Fab Equipment names slide after Micron cuts wafer starts
- 10/24/22
- Applied Materials appoints March to board of directors
- 10/19/22
- Microvast, Albemarle among infrastructure law funding recipients
- 09/11/22
- Fly Intel: Top five weekend stock stories
- $167.51 /
+10.76 (+6.86%) - 11/18/22 Evercore ISI
- Palo Alto Networks price target raised to $215 from $207 at Evercore ISI
- 11/18/22 BMO Capital
- Palo Alto Networks price target raised to $225 from $218 at BMO Capital
- 11/18/22 Morgan Stanley
- Palo Alto Networks 'ready to re-rate,' says Morgan Stanley
- 11/18/22 Deutsche Bank
- Palo Alto Networks price target raised to $217 from $209 at Deutsche Bank
- $104.70 /
+0.365 (+0.35%) - 11/18/22 DA Davidson
- Applied Materials price target raised to $125 from $105 at DA Davidson
- 11/18/22 Evercore ISI
- Applied Materials price target raised to $120 from $100 at Evercore ISI
- 11/18/22 Needham
- Applied Materials price target raised to $120 from $90 at Needham
- 11/18/22 Craig-Hallum
- Applied Materials price target raised to $126 from $95 at Craig-Hallum
- 11/18/22 Jefferies
- Gap price target raised to $13 from $11 at Jefferies
- 11/18/22 Wells Fargo
- Gap price target raised to $12 from $10 at Wells Fargo
- 11/18/22 Citi
- Gap 'not out of the woods yet' despite Q3 beat, says Citi
- 11/11/22 Citi
- Gap price target raised to $8 from $7 at Citi
- $35.49 /
+19.49 (+121.81%) - $214.51 /
+0.055 (+0.03%) - 11/14/22 Credit Suisse
- Honeywell assumed with a Neutral at Credit Suisse
- 10/31/22 Baird
- Honeywell price target raised to $225 from $202 at Baird
- 10/31/22 Daiwa
- Honeywell downgraded to Neutral from Outperform at Daiwa
- 10/28/22 RBC Capital
- Honeywell price target raised to $199 from $184 at RBC Capital
- 11/18/22 Mizuho
- Others gaining more share than Coinbase from FTX fall, says Mizuho
- 11/18/22 BofA
- Coinbase downgraded to Neutral at BofA amid clouds from FTX fallout
- 11/18/22 BofA
- Coinbase downgraded to Neutral from Buy at BofA
- 11/16/22 DA Davidson
- Coinbase price target lowered to $70 from $100 at DA Davidson
- 11/18/22 BofA
- HP Inc. price target lowered to $27 from $30 at BofA
- 11/18/22 Citi
- HP Inc. price target lowered to $31 from $33 at Citi
- 11/18/22 Credit Suisse
- HP Inc. downgraded to Neutral from Outperform at Credit Suisse
- 10/17/22 Morgan Stanley
- HP Inc. price target lowered to $24 from $28 at Morgan Stanley
WBA Walgreens Boots Alliance - 11/18/22 JPMorgan
- Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
- 11/11/22 Deutsche Bank
- Walgreens upgraded to Buy with $50 target at Deutsche Bank
- 11/11/22 Deutsche Bank
- Walgreens Boots Alliance upgraded to Buy from Hold at Deutsche Bank
- 11/08/22 Truist
- Walgreens Boots Alliance price target raised to $44 from $38 at Truist
- 11/18/22 Piper Sandler
- DraftKings initiated with an Overweight at Piper Sandler
- 11/07/22 Craig-Hallum
- DraftKings price target lowered to $21 from $30 at Craig-Hallum
- 11/07/22 Guggenheim
- DraftKings price target lowered to $27 from $31 at Guggenheim
- 11/07/22 Canaccord
- DraftKings price target lowered to $28 from $32 at Canaccord
- 11/18/22 Morgan Stanley
- Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
- 11/18/22 BofA
- Editas' EDIT-101 setback 'not the end of the story,' says BofA
- 11/18/22 RBC Capital
- Editas Medicine price target lowered to $14 from $32 at RBC Capital
- 11/18/22 Truist
- Editas Medicine price target lowered to $35 from $80 at Truist
- 10/17/22 Citi
- JPMorgan shares offer 'excellent entry point,' says Citi
- 10/17/22 BMO Capital
- JPMorgan price target raised to $158 from $149 at BMO Capital
- 10/05/22 Morgan Stanley
- JPMorgan price target lowered to $126 from $127 at Morgan Stanley
- 10/04/22 Citi
- Citi opens 'positive catalyst watch' on JPMorgan into results
- 11/14/22 Jefferies
- SoftBank Group downgraded to Underperform from Hold at Jefferies
- 10/26/22 Jefferies
- SoftBank Group downgraded to Hold from Buy at Jefferies
- 02/08/22 Citi
- Street largely expected Nvidia deal to fall through, says Citi
- 02/07/22 Citi
- Alibaba filing may suggest Softbank intention to sell shares, says Citi
- 11/18/22 JPMorgan
- CarMax price target lowered to $60 from $70 at JPMorgan
- 11/15/22 Oppenheimer
- Carvana downgraded to Perform from Outperform at Oppenheimer
- 11/07/22 Baird
- Carvana price target lowered to $30 from $65 at Baird
- 11/04/22 RBC Capital
- Carvana price target lowered to $14 from $35 at RBC Capital
- 11/15/22 Morgan Stanley
- Alphabet price target lowered to $120 from $125 at Morgan Stanley
- 11/10/22 BofA
- BofA downgrades Viant, sees things getting worse before better
- 11/09/22 Oppenheimer
- Trade Desk price target lowered to $60 from $78 at Oppenheimer
- 10/31/22 Morgan Stanley
- ADT Inc. resumed with an Equal Weight at Morgan Stanley
- 11/01/22 Morgan Stanley
- Live Nation price target lowered to $95 from $110 at Morgan Stanley
- 10/07/22 Guggenheim
- Live Nation price target lowered to $120 from $140 at Guggenheim
- 08/08/22 Credit Suisse
- Liberty SiriusXM price target lowered to $52 from $64 at Credit Suisse
- 08/08/22 Citi
- Live Nation price target raised to $100 from $93 at Citi
- 11/10/22 Jefferies
- Apellis downgraded to Hold at Jefferies after doctor survey
- 11/10/22 Jefferies
- Iveric bio downgraded to Hold at Jefferies after doctor survey
- 11/10/22 Jefferies
- Iveric bio downgraded to Hold from Buy at Jefferies
- 10/17/22 B. Riley
- Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
- $50.45 /
+7.215 (+16.69%) - 11/18/22 Cowen
- Apellis should trade to $70 upon pegectacoplan approval, says Cowen
- 11/10/22 Jefferies
- Apellis downgraded to Hold from Buy at Jefferies
- 11/17/22 Piper Sandler
- Ardelyx upgraded to Overweight from Neutral at Piper Sandler
- 08/18/22 Citi
- Ardelyx price target lowered to $10 from $12 at Citi
- 05/18/22 Piper Sandler
- Ardelyx price target lowered to $3 from $4 at Piper Sandler
- 05/06/22 Cantor Fitzgerald
- Ardelyx downgraded to Neutral from Overweight at Cantor Fitzgerald
- 11/02/22 H.C. Wainwright
- G1 Therapeutics price target lowered to $57 from $67 at H.C. Wainwright
- 09/16/22 Wedbush
- G1 Therapeutics price target raised to $25 from $20 at Wedbush
- 11/18/22 Morgan Stanley
- Farfetch price target lowered to $24 from $26 at Morgan Stanley
- 11/18/22 JPMorgan
- Farfetch earnings selloff a buying opportunity, says JPMorgan
- 11/18/22 BTIG
- Farfetch price target lowered to $13 from $16 at BTIG
- 10/25/22 Morgan Stanley
- Farfetch price target lowered to $26 from $32 at Morgan Stanley
- 11/14/22 Mizuho
- JD.com price target lowered to $82 from $90 at Mizuho
- 10/31/22 Morgan Stanley
- JD.com price target lowered to $55 from $80 at Morgan Stanley
- 10/28/22 Morgan Stanley
- JD.com named a 'Catalyst Driven Idea' at Morgan Stanley
- 10/28/22 Barclays
- JD.com price target lowered to $59 from $66 at Barclays
- 11/14/22 Deutsche Bank
- Foot Locker price target lowered to $31 from $34 at Deutsche Bank
- 11/11/22 Citi
- Citi cuts Foot Locker target, opens 'negative catalyst watch'
- 10/31/22 JPMorgan
- Foot Locker price target lowered to $37 from $40 at JPMorgan
- 08/23/22 Credit Suisse
- Foot Locker price target raised to $40 from $31 at Credit Suisse
- 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 09/16/22 Deutsche Bank
- Spectrum Brands price target lowered to $68 from $90 at Deutsche Bank
- 08/15/22 Deutsche Bank
- Spectrum Brands price target lowered to $90 from $95 at Deutsche Bank
- 08/15/22 UBS
- Spectrum Brands price target lowered to $100 from $109 at UBS
- 08/15/22 RBC Capital
- Spectrum Brands price target lowered to $109 from $120 at RBC Capital
- 11/18/22 Wells Fargo
- Williams-Sonoma price target lowered to $120 from $170 at Wells Fargo
- 11/18/22 Cowen
- Williams-Sonoma price target lowered to $145 from $170 at Cowen
- 11/18/22 RBC Capital
- Williams-Sonoma price target lowered to $151 from $192 at RBC Capital
- 11/11/22 JPMorgan
- Williams-Sonoma price target lowered to $131 from $143 at JPMorgan
- 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 08/24/22
- Williams-Sonoma backs FY22 and long term guidance
- 08/24/22
- Williams-Sonoma reports Q2 EPS $3.87, consensus $3.54
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/18/22
- Spectrum Brands sees FY23 revenue growth in low single-digits, consensus $3.3B
- 11/18/22
- Spectrum Brands reports Q4 EPS 48c, consensus 57c
- 08/12/22
- Spectrum Brands sees FY22 revenue growth mid-single digits, consensus $3.39B
- 08/12/22
- Spectrum Brands reports Q3 adjusted cont ops EPS 54c, consensus $1.50
- 08/08/22
- SoftBank Group reports (Y2.92T) investment loss at SoftBank Vision Funds in Q1
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- $167.51 /
+10.76 (+6.86%) - 11/17/22
- Palo Alto Networks sees FY23 adjusted EPS $3.37-$3.44, consensus $3.17
- 11/17/22
- Palo Alto Networks sees Q2 adjusted EPS 76c-78c, consensus 71c
- 11/17/22
- Palo Alto Networks reports Q1 adjusted EPS 83c, consensus 69c
- 11/17/22
- Notable companies reporting after market close
- 11/03/22
- Live Nation reports Q3 EPS $1.39, consensus $1.03
- 08/04/22
- Live Nation reports Q2 EPS 66c, consensus 51c
- 08/04/22
- Notable companies reporting after market close
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 10/13/22
- Notable companies reporting before tomorrow's open
- 07/14/22
- JPMorgan reports Q2 EPS $2.76, consensus $2.91
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 08/23/22
- JD.com reports Q2 adjusted EPS 61c, consensus 40c
- 11/03/22
- Iveric bio reports Q3 EPS (35c), consensus (40c)
- 07/26/22
- Iveric bio reports Q2 EPS (42c), consensus (31c)
- 08/30/22
- HP Inc. cuts FY22 EPS view to $4.02-$4.12 from $4.24-$4.38, consensus $4.30
- 08/30/22
- HP Inc. sees Q4 EPS 79c-89c, consensus $1.06
- 08/30/22
- HP Inc. reports Q3 EPS $1.04, consensus $1.04
- 08/30/22
- Notable companies reporting after market close
- $214.51 /
+0.055 (+0.03%) - 11/18/22
- Honeywell reaffirms Q4, 2022 guidance after asbestos settlement
- 10/27/22
- Honeywell sees Q4 adjusted EPS $2.46-$2.56, consensus $2.51
- 10/27/22
- Honeywell narrows FY22 adjusted EPS view to $8.70-$8.80 from $8.55-$8.80
- 10/27/22
- Honeywell reports Q3 adjusted EPS $2.25, consensus $2.16
- 11/02/22
- G1 Therapeutics reports Q3 EPS (59c), consensus (63c)
- 08/03/22
- G1 Therapeutics reports Q2 EPS (92c), consensus ($1.02)
- 11/17/22
- Gap reports Q3 Gap brand revenue $1.04B, flat y/y
- 11/17/22
- Gap sees Q4 revenue down mid-single digits, consensus $4.5B
- 11/17/22
- Gap reports Q3 adjusted EPS 71c, consensus 0c
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 11/17/22
- Farfetch reports Q3 adjusted EPS (24c), consensus (28c)
- 08/25/22
- Farfetch reports Q2 EPS (21c), consensus (32c)
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- 11/18/22
- Foot Locker sees Q4 EPS 45c-53c, consensus 43c
- 11/18/22
- Foot Locker reports Q3 EPS $1.27, consensus $1.11
- 11/17/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Editas Medicine reports Q3 EPS (81c), consensus (86c)
- 08/03/22
- Editas Medicine reports Q2 EPS (78c), consensus (82c)
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
- 11/03/22
- Carvana reports Q3 EPS ($2.67), consensus ($1.94)
- 08/04/22
- Carvana reports Q2 EPS ($2.35), consensus ($1.79)
- 11/03/22
- Coinbase reports Q3 EPS ($2.43), consensus ($2.40)
- 11/03/22
- Notable companies reporting after market close
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 11/03/22
- Ardelyx reports Q3 EPS (14c), consensus (17c)
- 08/04/22
- Ardelyx reports Q2 EPS (19c), consensus (19c)
- $104.70 /
+0.365 (+0.35%) - 11/17/22
- Applied Materials sees Q1 adjusted EPS $1.75-$2.11, consensus $1.83
- 11/17/22
- Applied Materials reports Q4 adjusted EPS $2.03, consensus $1.73
- 10/12/22
- Applied Materials cuts Q4 adjusted EPS view to $1.54-$1.78 from $1.82-$2.18
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/18/22
- Williams-Sonoma falls -9.7%
- 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 09/14/22
- Williams-Sonoma names Jeff Howie as new CFO
WBA Walgreens Boots Alliance - 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 11/02/22
- Walgreens Boots Alliance agrees to pay $4.95B to settle opioid claims
- 11/02/22
- Walgreens to pay about $5B to resolve some opioid lawsuits with states, tribes
- 11/02/22
- Western Union enters renewed five-year agreement with Walgreens
- 11/17/22
- Tiga Acquisition falls -11.6%
- 11/17/22
- Tiga Acquisition falls -13.3%
- 11/16/22
- Tiga Acquisition rises 33.1%
- 10/14/22
- Spectrum Brands responds to DOJ suit seeking to block sale of HHI segment
- 09/15/22
- Spectrum Brands falls -14.1%
- 09/15/22
- Assa Abloy says 'will vigorously contest' DOJ effort to block deal with Spectrum
- 09/15/22
- Spectrum Brands vows to 'vigorously oppose' DOJ suit on unit sale
- 08/10/22
- SoftBank board approves transfer of Alibaba shares to finance subsidiaries
- 08/09/22
- SoftBank to sell 'some or all of their holdings' in SoFi Technologies
- 06/22/22
- SoftBank Group International Michel Combes to step down, Alex Clavel to succeed
- 06/07/22
- Symbotic completes combination with SPAC SVF Investment
- $109.00 /
+11.13 (+11.37%) - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- $170.08 /
+13.33 (+8.50%) - 11/17/22
- Palo Alto Networks CEO: We're taking a knife to our costs
- 11/17/22
- Palo Alto Networks jumps 5% after Q1 results, FY23 guidance beat estimates
- 11/17/22
- Palo Alto Networks confirms agreement to acquire Cider Security for $195M cash
- 11/17/22
- Palo Alto Networks announces receipt of initial $67M purchase order from DOD
- 10/24/22
- Finexio closes $35M Series B funding round
- 10/23/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- Chase, Disney and Visa announce multi-year extension for Disney card programs
- 10/19/22
- Texas AG investigating six banks over consumer protection laws
- 11/16/22
- Else Nutrition launches on second online store, JD.com
- 08/23/22
- JD.com reports annual active customer accounts up 9.2% to 580.8M
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 06/29/22
- JD.com announces renewed strategic cooperation with Tencent
- $22.00 /
+4.785 (+27.80%) - 11/17/22
- Iveric bio announces FDA granted breakthrough designation for Zimura
- 11/03/22
- Iveric bio submits first part of NDA for rolling review of avacincaptad pegol
- 09/06/22
- Iveric bio says GATHER2 Phase 3 trial met primary endpoint
- 09/02/22
- Iveric bio reports inducement grants under Nasdaq Listing Rule
- 09/01/22
- Avid Technology to replace Plantronics in the S&P 600 at open on 9/1
- 08/30/22
- HP Inc. CEO: Supply chain situation is 'getting closer to normal'
- 08/29/22
- HP Inc. completes acquisition of Poly
- 11/02/22
- G1 Therapeutics reports data from first patients in Phase 2 study of trilaciclib
- 10/26/22
- G1 announces investigator-initiated study of trilaciclib, lurbinectedin
- 10/10/22
- G1 Therapeutics completes enrollment in Phase 3 clinical trial of trilaciclib
- 09/12/22
- Day One Biopharmaceuticals appoints Nicholson as chairman
- $44.60 /
+28.6 (+178.75%) - 11/18/22
- Grindr completes business combination, to begin trading on NYSE
- 11/17/22
- Gap rises 8% to nearly $14 after Q3 results
- 11/10/22
- Gap launches collection of 'family essentials' with Amazon Fashion
- 10/25/22
- Gap 'taking immediate steps' to remove Yeezy Gap product from stores
- 09/28/22
- Gap unit Athleta teams with thredUP, and Shop Premium Outlets for online
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 11/14/22
- Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes
- 11/14/22
- Google debuts Health Connect beta, supports Peloton, Oura, WeightWatchers apps
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 11/14/22
- Tiger Global takes stakes in Visa, Mastercard, exits position in Flywire
- 11/10/22
- FTC restores rigorous enforcement of law banning unfair methods of competition
- 11/18/22
- Farfetch falls -14.1%
- 11/18/22
- Farfetch falls -12.0%
- 10/21/22
- Farfetch announces first cohort of start-ups for Dream Assembly Base Camp
- 08/29/22
- Farfetch falls -11.9%
- 11/18/22
- Foot Locker rises 14.7%
- 11/18/22
- Foot Locker rises 15.8%
- 11/18/22
- Foot Locker says sustained momentum throughout Q3
- 11/18/22
- Foot Locker jumps 17% to $38.80 after Q3 results beat, FY22 guidance raised
- 11/17/22
- Editas sinks 17% to $10.11 after pausing BRILLIANCE study enrollment
- 11/17/22
- Editas Medicine announces clinical data from Phase 1/2 BRILLIANCE trial
- 10/18/22
- Editas Medicine rises after report of talks to sell preclinical oncology assets
- 10/13/22
- Editas Medicine presents preclinical data on EDIT-103 for RHO-adRP
- 11/18/22
- DraftKings to launch online sportsbook in Maryland on November 23
- 11/09/22
- DraftKings lower after California voters reject sports betting measures
- 11/04/22
- DraftKings CEO: Right in line on where we thought we'd be with user growth
- 10/27/22
- Nevada reports September statewide gaming win up 7.87% to $1.25B
- 11/14/22
- Carvana falls -15.7%
- 11/11/22
- Carvana trading resumes
- 11/11/22
- Carvana trading halted, volatility trading pause
- 11/07/22
- Carvana falls -15.4%
- 11/16/22
- Cathie Wood's ARK Investment bought 245.6K shares of Coinbase today
- 11/16/22
- Coinbase says has 'zero exposure' to Genesis Trading
- 11/11/22
- FTX commences Chapter 11 proceedings, Bankman-Fried resigns
- 11/10/22
- FTX US says trading may be halted 'in a few days'
- $117.41 /
+24.81 (+26.79%) - 11/18/22
- Clearfield jumps 15% to $107.06 after Q4 beat, above-consensus outlook
- 08/10/22
- Clearfield to replace Celsius Holdings in S&P 600 at open on 8/10
- 07/27/22
- Clearfield closes acquisition of Nestor Cables
- 11/17/22
- Ardelyx director Mott acquires 567,000 common shares
- 11/16/22
- Ardelyx trading resumes
- 11/16/22
- Ardelyx's Xphozah for kidney disease receives favorable FDA vote
- 11/16/22
- Nasdaq halts trading of Ardelyx common stock
- 11/18/22
- Apellis announces FDA accepts NDA amendment, new PDUFA date for pegcetacoplan
- 11/03/22
- Apellis provides update on intravitreal pegcetacoplan NDA
- 11/03/22
- Apellis to present long-term data on efficacy, safety profile of EMPAVELI
- 09/30/22
- Apellis announces four presentations of data from Phase 3 DERBY, OAKS studies
- 11/17/22
- Amazon.com exec sells $1.63M in common stock
- 11/17/22
- Amazon cuts jobs across Devices, Books units, offers reduction for PXT staff
- 11/16/22
- Amazon and Azul in pact for speedier deliveries in Brazil
- 11/16/22
- Peloton expands collaboration with Amazon.com in U.K., Germany
- 11/16/22
- Wafer Fab Equipment names slide after Micron cuts wafer starts
- 10/24/22
- Applied Materials appoints March to board of directors
- 10/19/22
- Microvast, Albemarle among infrastructure law funding recipients
- 09/11/22
- Fly Intel: Top five weekend stock stories
- $170.08 /
+13.33 (+8.50%) - 11/18/22 Evercore ISI
- Palo Alto Networks price target raised to $215 from $207 at Evercore ISI
- 11/18/22 BMO Capital
- Palo Alto Networks price target raised to $225 from $218 at BMO Capital
- 11/18/22 Morgan Stanley
- Palo Alto Networks 'ready to re-rate,' says Morgan Stanley
- 11/18/22 Deutsche Bank
- Palo Alto Networks price target raised to $217 from $209 at Deutsche Bank
- 11/18/22 DA Davidson
- Applied Materials price target raised to $125 from $105 at DA Davidson
- 11/18/22 Evercore ISI
- Applied Materials price target raised to $120 from $100 at Evercore ISI
- 11/18/22 Needham
- Applied Materials price target raised to $120 from $90 at Needham
- 11/18/22 Craig-Hallum
- Applied Materials price target raised to $126 from $95 at Craig-Hallum
- 11/18/22 Jefferies
- Gap price target raised to $13 from $11 at Jefferies
- 11/18/22 Wells Fargo
- Gap price target raised to $12 from $10 at Wells Fargo
- 11/18/22 Citi
- Gap 'not out of the woods yet' despite Q3 beat, says Citi
- 11/11/22 Citi
- Gap price target raised to $8 from $7 at Citi
- 11/14/22 Deutsche Bank
- Foot Locker price target lowered to $31 from $34 at Deutsche Bank
- 11/11/22 Citi
- Citi cuts Foot Locker target, opens 'negative catalyst watch'
- 10/31/22 JPMorgan
- Foot Locker price target lowered to $37 from $40 at JPMorgan
- 08/23/22 Credit Suisse
- Foot Locker price target raised to $40 from $31 at Credit Suisse
- 11/14/22 Mizuho
- JD.com price target lowered to $82 from $90 at Mizuho
- 10/31/22 Morgan Stanley
- JD.com price target lowered to $55 from $80 at Morgan Stanley
- 10/28/22 Morgan Stanley
- JD.com named a 'Catalyst Driven Idea' at Morgan Stanley
- 10/28/22 Barclays
- JD.com price target lowered to $59 from $66 at Barclays
- 11/18/22 Mizuho
- Others gaining more share than Coinbase from FTX fall, says Mizuho
- 11/18/22 BofA
- Coinbase downgraded to Neutral at BofA amid clouds from FTX fallout
- 11/18/22 BofA
- Coinbase downgraded to Neutral from Buy at BofA
- 11/16/22 DA Davidson
- Coinbase price target lowered to $70 from $100 at DA Davidson
- 11/18/22 BofA
- HP Inc. price target lowered to $27 from $30 at BofA
- 11/18/22 Citi
- HP Inc. price target lowered to $31 from $33 at Citi
- 11/18/22 Credit Suisse
- HP Inc. downgraded to Neutral from Outperform at Credit Suisse
- 10/17/22 Morgan Stanley
- HP Inc. price target lowered to $24 from $28 at Morgan Stanley
- 11/18/22 Piper Sandler
- DraftKings initiated with an Overweight at Piper Sandler
- 11/07/22 Craig-Hallum
- DraftKings price target lowered to $21 from $30 at Craig-Hallum
- 11/07/22 Guggenheim
- DraftKings price target lowered to $27 from $31 at Guggenheim
- 11/07/22 Canaccord
- DraftKings price target lowered to $28 from $32 at Canaccord
WBA Walgreens Boots Alliance - 11/18/22 JPMorgan
- Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
- 11/11/22 Deutsche Bank
- Walgreens upgraded to Buy with $50 target at Deutsche Bank
- 11/11/22 Deutsche Bank
- Walgreens Boots Alliance upgraded to Buy from Hold at Deutsche Bank
- 11/08/22 Truist
- Walgreens Boots Alliance price target raised to $44 from $38 at Truist
- 10/17/22 Citi
- JPMorgan shares offer 'excellent entry point,' says Citi
- 10/17/22 BMO Capital
- JPMorgan price target raised to $158 from $149 at BMO Capital
- 10/05/22 Morgan Stanley
- JPMorgan price target lowered to $126 from $127 at Morgan Stanley
- 10/04/22 Citi
- Citi opens 'positive catalyst watch' on JPMorgan into results
- 11/14/22 Jefferies
- SoftBank Group downgraded to Underperform from Hold at Jefferies
- 10/26/22 Jefferies
- SoftBank Group downgraded to Hold from Buy at Jefferies
- 02/08/22 Citi
- Street largely expected Nvidia deal to fall through, says Citi
- 02/07/22 Citi
- Alibaba filing may suggest Softbank intention to sell shares, says Citi
- 11/18/22 JPMorgan
- CarMax price target lowered to $60 from $70 at JPMorgan
- 11/15/22 Oppenheimer
- Carvana downgraded to Perform from Outperform at Oppenheimer
- 11/07/22 Baird
- Carvana price target lowered to $30 from $65 at Baird
- 11/04/22 RBC Capital
- Carvana price target lowered to $14 from $35 at RBC Capital
- 11/15/22 Morgan Stanley
- Alphabet price target lowered to $120 from $125 at Morgan Stanley
- 11/10/22 BofA
- BofA downgrades Viant, sees things getting worse before better
- 11/09/22 Oppenheimer
- Trade Desk price target lowered to $60 from $78 at Oppenheimer
- 10/31/22 Morgan Stanley
- ADT Inc. resumed with an Equal Weight at Morgan Stanley
- 11/18/22 Erste Group
- Amazon.com downgraded to Hold from Buy at Erste Group
- 11/15/22 MoffettNathanson
- Amazon.com initiated with an Outperform at MoffettNathanson
- 11/14/22 JMP Securities
- Amazon lay off news 'not surprising,' says JMP Securities
- 11/14/22 BofA
- Amazon.com removed from 'US 1 List' at BofA
- $117.41 /
+24.81 (+26.79%) - 11/18/22 Needham
- Clearfield price target raised to $135 from $115 at Needham
- 11/18/22 Lake Street
- Clearfield price target raised to $135 from $122 at Lake Street
- 11/18/22 Northland
- Clearfield price target raised to $120 from $110 at Northland
- 10/18/22 Needham
- Clearfield price target raised to $115 from $110 at Needham
- $109.00 /
+11.13 (+11.37%) - 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 09/16/22 Deutsche Bank
- Spectrum Brands price target lowered to $68 from $90 at Deutsche Bank
- 08/15/22 Deutsche Bank
- Spectrum Brands price target lowered to $90 from $95 at Deutsche Bank
- 08/15/22 UBS
- Spectrum Brands price target lowered to $100 from $109 at UBS
- 08/15/22 RBC Capital
- Spectrum Brands price target lowered to $109 from $120 at RBC Capital
- 11/18/22 Wells Fargo
- Williams-Sonoma price target lowered to $120 from $170 at Wells Fargo
- 11/18/22 Cowen
- Williams-Sonoma price target lowered to $145 from $170 at Cowen
- 11/18/22 RBC Capital
- Williams-Sonoma price target lowered to $151 from $192 at RBC Capital
- 11/11/22 JPMorgan
- Williams-Sonoma price target lowered to $131 from $143 at JPMorgan
- $44.60 /
+28.6 (+178.75%) - $22.00 /
+4.785 (+27.80%) - 11/10/22 Jefferies
- Apellis downgraded to Hold at Jefferies after doctor survey
- 11/10/22 Jefferies
- Iveric bio downgraded to Hold at Jefferies after doctor survey
- 11/10/22 Jefferies
- Iveric bio downgraded to Hold from Buy at Jefferies
- 10/17/22 B. Riley
- Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
- 11/10/22 Jefferies
- Apellis downgraded to Hold from Buy at Jefferies
- 11/08/22 Wedbush
- Apellis price target lowered to $47 from $59 at Wedbush
- 11/17/22 Piper Sandler
- Ardelyx upgraded to Overweight from Neutral at Piper Sandler
- 08/18/22 Citi
- Ardelyx price target lowered to $10 from $12 at Citi
- 05/18/22 Piper Sandler
- Ardelyx price target lowered to $3 from $4 at Piper Sandler
- 05/06/22 Cantor Fitzgerald
- Ardelyx downgraded to Neutral from Overweight at Cantor Fitzgerald
- 11/02/22 H.C. Wainwright
- G1 Therapeutics price target lowered to $57 from $67 at H.C. Wainwright
- 09/16/22 Wedbush
- G1 Therapeutics price target raised to $25 from $20 at Wedbush
- 11/18/22 Morgan Stanley
- Farfetch price target lowered to $24 from $26 at Morgan Stanley
- 11/18/22 JPMorgan
- Farfetch earnings selloff a buying opportunity, says JPMorgan
- 11/18/22 BTIG
- Farfetch price target lowered to $13 from $16 at BTIG
- 10/25/22 Morgan Stanley
- Farfetch price target lowered to $26 from $32 at Morgan Stanley
- 11/18/22 Morgan Stanley
- Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
- 11/18/22 BofA
- Editas' EDIT-101 setback 'not the end of the story,' says BofA
- 11/18/22 RBC Capital
- Editas Medicine price target lowered to $14 from $32 at RBC Capital
- 11/18/22 Truist
- Editas Medicine price target lowered to $35 from $80 at Truist
- 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 08/24/22
- Williams-Sonoma backs FY22 and long term guidance
- 08/24/22
- Williams-Sonoma reports Q2 EPS $3.87, consensus $3.54
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/18/22
- Spectrum Brands sees FY23 revenue growth in low single-digits, consensus $3.3B
- 11/18/22
- Spectrum Brands reports Q4 EPS 48c, consensus 57c
- 08/12/22
- Spectrum Brands sees FY22 revenue growth mid-single digits, consensus $3.39B
- 08/12/22
- Spectrum Brands reports Q3 adjusted cont ops EPS 54c, consensus $1.50
- 08/08/22
- SoftBank Group reports (Y2.92T) investment loss at SoftBank Vision Funds in Q1
- $109.00 /
+11.13 (+11.37%) - 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- $170.08 /
+13.33 (+8.50%) - 11/17/22
- Palo Alto Networks sees FY23 adjusted EPS $3.37-$3.44, consensus $3.17
- 11/17/22
- Palo Alto Networks sees Q2 adjusted EPS 76c-78c, consensus 71c
- 11/17/22
- Palo Alto Networks reports Q1 adjusted EPS 83c, consensus 69c
- 11/17/22
- Notable companies reporting after market close
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 10/13/22
- Notable companies reporting before tomorrow's open
- 07/14/22
- JPMorgan reports Q2 EPS $2.76, consensus $2.91
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 08/23/22
- JD.com reports Q2 adjusted EPS 61c, consensus 40c
- $22.00 /
+4.785 (+27.80%) - 11/03/22
- Iveric bio reports Q3 EPS (35c), consensus (40c)
- 07/26/22
- Iveric bio reports Q2 EPS (42c), consensus (31c)
- 08/30/22
- HP Inc. cuts FY22 EPS view to $4.02-$4.12 from $4.24-$4.38, consensus $4.30
- 08/30/22
- HP Inc. sees Q4 EPS 79c-89c, consensus $1.06
- 08/30/22
- HP Inc. reports Q3 EPS $1.04, consensus $1.04
- 08/30/22
- Notable companies reporting after market close
- 11/02/22
- G1 Therapeutics reports Q3 EPS (59c), consensus (63c)
- 08/03/22
- G1 Therapeutics reports Q2 EPS (92c), consensus ($1.02)
- 11/17/22
- Gap reports Q3 Gap brand revenue $1.04B, flat y/y
- 11/17/22
- Gap sees Q4 revenue down mid-single digits, consensus $4.5B
- 11/17/22
- Gap reports Q3 adjusted EPS 71c, consensus 0c
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 11/17/22
- Farfetch reports Q3 adjusted EPS (24c), consensus (28c)
- 08/25/22
- Farfetch reports Q2 EPS (21c), consensus (32c)
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- 11/18/22
- Foot Locker sees Q4 EPS 45c-53c, consensus 43c
- 11/18/22
- Foot Locker reports Q3 EPS $1.27, consensus $1.11
- 11/17/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Editas Medicine reports Q3 EPS (81c), consensus (86c)
- 08/03/22
- Editas Medicine reports Q2 EPS (78c), consensus (82c)
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
- 11/03/22
- Carvana reports Q3 EPS ($2.67), consensus ($1.94)
- 08/04/22
- Carvana reports Q2 EPS ($2.35), consensus ($1.79)
- 11/03/22
- Coinbase reports Q3 EPS ($2.43), consensus ($2.40)
- 11/03/22
- Notable companies reporting after market close
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- $117.41 /
+24.81 (+26.79%) - 11/18/22
- Clearfield sees fiscal 2023 revenue $380M-$393M, consensus $299.49M
- 11/18/22
- Clearfield reports Q4 EPS $1.22, consensus 86c
- 07/28/22
- Clearfield sees FY22 revenue $243M-$247M, consensus $215.63M
- 07/28/22
- Clearfield reports Q3 EPS 92c, consensus 66c
- 11/03/22
- Ardelyx reports Q3 EPS (14c), consensus (17c)
- 08/04/22
- Ardelyx reports Q2 EPS (19c), consensus (19c)
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 10/27/22
- Notable companies reporting after market close
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 11/17/22
- Applied Materials sees Q1 adjusted EPS $1.75-$2.11, consensus $1.83
- 11/17/22
- Applied Materials reports Q4 adjusted EPS $2.03, consensus $1.73
- 10/12/22
- Applied Materials cuts Q4 adjusted EPS view to $1.54-$1.78 from $1.82-$2.18
|
Options
|
Notable gainers among… Notable gainers among liquid option names this morning include Ross Stores (ROST) $112.88 +14.94, Bath & Body Works (BBWI) $40.94 +1.97, Keysight Technologies (KEYS) $171.69 +5.66, V F Corp (VFC) $33.69 +1.09, and General Motors (GM) $39.80 +1.16. ShowHide Related Items >><< - 11/14/22
- VF Corp. releases FY22 annual profile on IDEA
- 10/26/22
- VF Corp. sees FY23 North Face revenue up at least 12%
- 09/28/22
- VF Corp. introduces FY27 targets at investor day
- 07/28/22
- VF Corp. reports Q2 Vans revenue down 7% y/y at $946.8M
- $112.69 /
+14.82 (+15.14%) - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
KEYS Keysight Technologies - $170.74 /
+5.025 (+3.03%) - 11/09/22
- Nokia Bell Labs selects Keysight's sub-THz test bed to verify TRX modules
- 10/04/22
- Keysight Technologies SVP Page sells 6,910
- 09/21/22
- Keysight Technologies, Jiyun Technologies collaborate on battery test system
- 09/08/22
- Keysight Technologies signs MOU with IBM for RAN deployments in Europe
- 11/17/22
- GM projects company revenue to grow at 12% compound annual rate through 2025
- 11/17/22
- GM sees EV adoption to approach 20% of U.S. industry sales in 2025
- 11/17/22
- General Motors, Vale sign long-term nickel supply agreement
- 11/17/22
- General Motors sees Brightdrop revenue at $1B annually by 2025, says Barra
- 11/17/22
- Bath & Body Works rises 19.7%
- 11/17/22
- Bath & Body Works rises 24.8%
- 11/17/22
- Bath & Body Works rises 22.2%
- 11/17/22
- Bath & Body Works: More than 21M members enrolled in loyalty program
- $112.69 /
+14.82 (+15.14%) - 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/18/22 Citi
- Bath & Body Works price target raised to $50 from $48 at Citi
- 11/17/22 Morgan Stanley
- Bath & Body Works price target raised to $76 from $72 at Morgan Stanley
- 11/17/22 BofA
- Bath & Body Works price target raised to $50 from $48 at BofA
- 11/17/22 Wells Fargo
- Bath & Body Works price target raised to $55 from $50 at Wells Fargo
KEYS Keysight Technologies - $170.74 /
+5.025 (+3.03%) - 11/18/22 Susquehanna
- Keysight Technologies price target lowered to $200 from $205 at Susquehanna
- 11/18/22 Deutsche Bank
- Keysight price target lowered to $190 from $193 at Deutsche Bank
- 11/03/22 Wells Fargo
- Keysight Technologies initiated with an Overweight at Wells Fargo
- 10/10/22 JPMorgan
- Keysight Technologies price target raised to $225 from $215 at JPMorgan
- 10/27/22 Wedbush
- VF Corp. price target lowered to $29 from $35 at Wedbush
- 10/27/22 JPMorgan
- VF downgraded to Underweight with $29 target at JPMorgan
- 10/27/22 Baird
- VF Corp. price target lowered to $40 from $45 at Baird
- 10/27/22 Credit Suisse
- VF Corp. price target lowered to $36 from $45 at Credit Suisse
- 11/18/22 Wedbush
- GM's Investor Day event 'impressive,' says Wedbush
- 11/10/22 Wolfe Research
- General Motors downgraded to Peer Perform from Outperform at Wolfe Research
- 10/26/22 Deutsche Bank
- General Motors price target lowered to $35 from $36 at Deutsche Bank
- 10/26/22 JPMorgan
- General Motors price target raised to $59 from $58 at JPMorgan
- 10/26/22
- VF Corp. cuts FY23 adjusted EPS $2.40-$2.50 from $2.60-$2.70
- 10/26/22
- VF Corp. reports Q2 adjusted EPS 73c, consensus 73c
- 10/26/22
- Notable companies reporting after market close
- 09/28/22
- VF Corp. sees Q2 adjusted EPS 70c-75c, consensus $1.00
- $112.69 /
+14.82 (+15.14%) - 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
KEYS Keysight Technologies - $170.74 /
+5.025 (+3.03%) - 11/17/22
- Keysight Technologies sees Q1 adjusted EPS $1.81-$1.87, consensus $1.81
- 11/17/22
- Keysight Technologies reports Q4 adjusted EPS $2.14, consensus $1.99
- 08/17/22
- Keysight Technologies sees Q4 adjusted EPS $1.94-$2.00, consensus $1.89
- 08/17/22
- Keysight Technologies reports Q3 adjusted EPS $2.01, consensus $1.78
- 11/17/22
- General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B
- 10/25/22
- General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79
- 10/25/22
- General Motors reports Q3 adjusted EPS $2.25, consensus $1.88
- 10/24/22
- Notable companies reporting before tomorrow's open
- 11/17/22
- Bath & Body Works sees FY22 sales down mid single digits vs. 2021
- 11/17/22
- Bath & Body Works sees Q4 sales down mid single to low double digits vs. 2021
- 11/16/22
- Bath & Body Works raises FY22 EPS view to $3.00-$3.20 from $2.70-$3.00
- 11/16/22
- Bath & Body Works sees Q4 EPS $1.45-$1.65, consensus $1.55
- $112.69 /
+14.82 (+15.14%) - 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- 11/11/22
- Ford, GM in talks with Posco on battery metal hubs, Bloomberg reports
- 10/31/22
- EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says
- 10/28/22
- General Motors temporarily suspends advertising on Twitter, CNBC says
- 10/27/22
- EU strikes deal to ban new combustion engine cars from 2035, Bloomberg says
- 10/27/22
- What You Missed On Wall Street On Thursday
- 10/27/22
- What You Missed On Wall Street This Morning
- 10/27/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/28/22
- What You Missed On Wall Street On Wednesday
- $112.69 /
+14.82 (+15.14%) - 11/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/18/22
- Fly Intel: Pre-market Movers
- 11/17/22
- Fly Intel: After-Hours Movers
- 10/25/22
- What You Missed On Wall Street On Tuesday
KEYS Keysight Technologies - $170.74 /
+5.025 (+3.03%) - 11/03/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/18/22
- What You Missed On Wall Street This Morning
- 11/14/22
- What You Missed This Week in EVs and Clean Energy
- 11/11/22
- What You Missed On Wall Street On Friday
- 11/11/22
- What You Missed On Wall Street This Morning
- 11/17/22
- What You Missed On Wall Street On Thursday
- 11/17/22
- What You Missed On Wall Street This Morning
- 11/16/22
- Fly Intel: After-Hours Movers
- 08/18/22
- What You Missed On Wall Street On Thursday
- 10/26/22
- V F Corp options imply 5.9% move in share price post-earnings
- 09/29/22
- V F Corp put volume heavy and directionally bearish
- 09/27/22
- V F Corp call volume above normal and directionally bullish
- 09/13/22
- Unusually active option classes on open September 13th
- $112.69 /
+14.82 (+15.14%) - 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
- 05/23/22
- Early notable gainers among liquid option names on May 23rd
- 05/19/22
- Ross Stores options imply 8.6% move in share price post-earnings
KEYS Keysight Technologies - $170.74 /
+5.025 (+3.03%) - 08/18/22
- Early notable gainers among liquid option names on August 18th
- 10/21/22
- General Motors call volume above normal and directionally bullish
- 09/29/22
- Unusually active option classes on open September 29th
- 09/27/22
- General Motors put volume heavy and directionally bearish
- 08/31/22
- Unusually active option classes on open August 31st
- 11/17/22
- Early notable gainers among liquid option names on November 17th
- 11/16/22
- Bath & Body Works options imply 10.3% move in share price post-earnings
- 10/24/22
- Bath & Body Works call volume above normal and directionally bullish
- 08/19/22
- Bath & Body Works put volume heavy and directionally bearish
|
Recommendations
|
BMO Capital analyst… BMO Capital analyst Simeon Siegel raised the firm's price target on Ross Stores to $113 from $95 and keeps an Outperform rating on the shares. The company's Q3 results were "strong" with better than expected sales and margins, while its management's above-consensus guidance for Q4 was "somewhat unusual", the analyst tells investors in a research note. Siegel adds that he continues to see Ross Store as a long-term market share taker and believes that the sector-wide inventory and promotions provide added tailwinds for the stock. ShowHide Related Items >><< - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/18/22 Baird
- Ross Stores price target raised to $125 from $105 at Baird
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- 11/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/18/22
- Fly Intel: Pre-market Movers
- 11/17/22
- Fly Intel: After-Hours Movers
- 10/25/22
- What You Missed On Wall Street On Tuesday
- 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
- 05/23/22
- Early notable gainers among liquid option names on May 23rd
- 05/19/22
- Ross Stores options imply 8.6% move in share price post-earnings
|
On The Fly
| ShowHide Related Items >><< WBA Walgreens Boots Alliance - 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 11/02/22
- Walgreens Boots Alliance agrees to pay $4.95B to settle opioid claims
- 11/02/22
- Walgreens to pay about $5B to resolve some opioid lawsuits with states, tribes
- 11/02/22
- Western Union enters renewed five-year agreement with Walgreens
- 11/16/22
- TJX expects to repurchase $2.25B-$2.5B of TJX stock this FY
- 11/16/22
- TJX sees freight as a tailwind next year
- 11/16/22
- TJX: Comp sales improved each month of Q3 on 3-year stacked basis
- 11/16/22
- TJX promotes John Klinger to CFO effective January 29
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/14/22
- Berkshire Hathaway adds TSMC, exits STORE Capital in Q3
- 10/06/22
- TD Bank announces new financing partnership with RH
- 06/30/22
- RH falls -11.1%
- 06/30/22
- RH falls -8.2%
- 09/12/22
- Rent The Runway drops 22% to $3.83 after lowering FY23 revenue outlook
- 09/12/22
- Rent The Runway announces corporate workforce reductions of 24%, restructuring
- 11/14/22
- Merck, AstraZeneca announce EMA's CHMP adopted positive opinion of LYNPARZA
- 11/14/22
- AstraZeneca Lynparza+biraterone recommended for E.U. approval in mCRPC
- 11/11/22
- Intensity Therapeutics' INT230-6 increases survival in solid tumor cancers
- 11/10/22
- Immutep announces clinical results from Phase II trial of eftilagimod alpha
- 10/19/22
- Insmed to sell 13.75M shares of its common stock
- 10/19/22
- Insmed announces three strategic financings totaling $775M
- 09/07/22
- Insmed reports inducement grants under NASDAQ listing rule
- 07/08/22
- Insmed reports inducement grants under NASDAQ listing rule
- 09/01/22
- Avid Technology to replace Plantronics in the S&P 600 at open on 9/1
- 08/30/22
- HP Inc. CEO: Supply chain situation is 'getting closer to normal'
- 08/29/22
- HP Inc. completes acquisition of Poly
- 11/17/22
- Editas sinks 17% to $10.11 after pausing BRILLIANCE study enrollment
- 11/17/22
- Editas Medicine announces clinical data from Phase 1/2 BRILLIANCE trial
- 10/18/22
- Editas Medicine rises after report of talks to sell preclinical oncology assets
- 10/13/22
- Editas Medicine presents preclinical data on EDIT-103 for RHO-adRP
- 11/16/22
- Restaurant Brands appoints Patrick Doyle as executive chairman
- 11/15/22
- Pershing Square exits Domino's, boosts stake in Canadian Pacific in Q3
- 10/13/22
- Domino's Pizza reported Q3 global net store growth of 225
- 08/15/22
- Pershing Square exits Netflix in Q2
- 11/18/22
- DraftKings to launch online sportsbook in Maryland on November 23
- 11/09/22
- DraftKings lower after California voters reject sports betting measures
- 11/04/22
- DraftKings CEO: Right in line on where we thought we'd be with user growth
- 10/27/22
- Nevada reports September statewide gaming win up 7.87% to $1.25B
- 11/17/22
- Amazon.com exec sells $1.63M in common stock
- 11/17/22
- Amazon cuts jobs across Devices, Books units, offers reduction for PXT staff
- 11/16/22
- Amazon and Azul in pact for speedier deliveries in Brazil
- 11/16/22
- Peloton expands collaboration with Amazon.com in U.K., Germany
- 11/16/22
- Wafer Fab Equipment names slide after Micron cuts wafer starts
- 10/24/22
- Applied Materials appoints March to board of directors
- 10/19/22
- Microvast, Albemarle among infrastructure law funding recipients
- 09/11/22
- Fly Intel: Top five weekend stock stories
- 11/18/22 BofA
- HP Inc. price target lowered to $27 from $30 at BofA
- 11/18/22 Citi
- HP Inc. price target lowered to $31 from $33 at Citi
- 11/18/22 Credit Suisse
- HP Inc. downgraded to Neutral from Outperform at Credit Suisse
- 10/17/22 Morgan Stanley
- HP Inc. price target lowered to $24 from $28 at Morgan Stanley
- 11/18/22 Piper Sandler
- DraftKings initiated with an Overweight at Piper Sandler
- 11/07/22 Craig-Hallum
- DraftKings price target lowered to $21 from $30 at Craig-Hallum
- 11/07/22 Guggenheim
- DraftKings price target lowered to $27 from $31 at Guggenheim
- 11/07/22 Canaccord
- DraftKings price target lowered to $28 from $32 at Canaccord
- 11/18/22 Morgan Stanley
- Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
- 11/18/22 BofA
- Editas' EDIT-101 setback 'not the end of the story,' says BofA
- 11/18/22 RBC Capital
- Editas Medicine price target lowered to $14 from $32 at RBC Capital
- 11/18/22 Truist
- Editas Medicine price target lowered to $35 from $80 at Truist
- 11/18/22 Morgan Stanley
- Rent The Runway downgraded to Equal Weight from Overweight at Morgan Stanley
- 09/13/22 Morgan Stanley
- Rent The Runway price target lowered to $13 from $14 at Morgan Stanley
- 09/13/22 JMP Securities
- Rent The Runway price target lowered to $6 from $12 at JMP Securities
- 09/13/22 Barclays
- Rent The Runway price target lowered to $6 from $7 at Barclays
- 11/17/22 Credit Suisse
- Merck initiated with an Outperform at Credit Suisse
- 11/01/22 Oppenheimer
- Merck pact shows Veeva life science vendor of choice, says Oppenheimer
- 11/01/22 Guggenheim
- Merck price target raised to $111 from $104 at Guggenheim
- 10/28/22 Morgan Stanley
- Merck price target raised to $100 from $91 at Morgan Stanley
- 11/18/22 Wedbush
- Wedbush downgrades RH on 'course-correction,' deteriorating macro
- 11/18/22 Wedbush
- RH downgraded to Neutral from Outperform at Wedbush
- 10/31/22 Citi
- RH price target lowered to $305 from $338 at Citi
- 09/21/22 William Blair
- RH resumed with an Outperform at William Blair
- 11/18/22 Raymond James
- Fulgent Genetics initiated with an Outperform at Raymond James
- 11/14/22 Credit Suisse
- Fulgent Genetics price target lowered to $50 from $65 at Credit Suisse
- 11/14/22 Piper Sandler
- Fulgent Genetics price target lowered to $65 from $70 at Piper Sandler
- 08/24/22 Credit Suisse
- Fulgent Genetics initiated with an Outperform at Credit Suisse
WBA Walgreens Boots Alliance - 11/18/22 JPMorgan
- Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
- 11/11/22 Deutsche Bank
- Walgreens upgraded to Buy with $50 target at Deutsche Bank
- 11/11/22 Deutsche Bank
- Walgreens Boots Alliance upgraded to Buy from Hold at Deutsche Bank
- 11/08/22 Truist
- Walgreens Boots Alliance price target raised to $44 from $38 at Truist
- 11/18/22 DA Davidson
- Applied Materials price target raised to $125 from $105 at DA Davidson
- 11/18/22 Evercore ISI
- Applied Materials price target raised to $120 from $100 at Evercore ISI
- 11/18/22 Needham
- Applied Materials price target raised to $120 from $90 at Needham
- 11/18/22 Craig-Hallum
- Applied Materials price target raised to $126 from $95 at Craig-Hallum
- 11/18/22 BMO Capital
- Ross Stores price target raised to $113 from $95 at BMO Capital
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/18/22 Gordon Haskett
- Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
- 11/18/22 Barclays
- TJX price target raised to $94 from $76 at Barclays
- 11/17/22 Telsey Advisory
- TJX price target raised to $95 from $86 at Telsey Advisory
- 11/17/22 BofA
- TJX price target raised to $90 from $80 at BofA
- 11/18/22 Guggenheim
- Pinnacle West upgraded to Neutral from Sell at Guggenheim
- 11/17/22 Wolfe Research
- Pinnacle West upgraded to Peer Perform at Wolfe on better view in Arizona
- 11/17/22 Wolfe Research
- Pinnacle West upgraded to Peer Perform from Underperform at Wolfe Research
- 10/24/22 Guggenheim
- Pinnacle West price target lowered to $54 from $60 at Guggenheim
- 11/18/22 Northcoast
- Domino's Pizza upgraded to Buy from Neutral at Northcoast
- 10/14/22 BMO Capital
- Domino's Pizza price target lowered to $400 from $430 at BMO Capital
- 10/14/22 Argus
- Domino's Pizza impacted by driver shortages and higher costs, says Argus
- 10/14/22 Deutsche Bank
- Domino's Pizza price target lowered to $359 from $373 at Deutsche Bank
- 11/18/22 Erste Group
- Amazon.com downgraded to Hold from Buy at Erste Group
- 11/15/22 MoffettNathanson
- Amazon.com initiated with an Outperform at MoffettNathanson
- 11/14/22 JMP Securities
- Amazon lay off news 'not surprising,' says JMP Securities
- 11/14/22 BofA
- Amazon.com removed from 'US 1 List' at BofA
- 11/18/22 BofA
- BofA starts Insmed at Buy on strong fundamentals and differentiated pipeline
- 11/18/22 BofA
- Insmed initiated with a Buy at BofA
- 10/25/22 Cantor Fitzgerald
- Insmed price target lowered to $49 from $53 at Cantor Fitzgerald
- 10/21/22 Cowen
- Insmed price target lowered to $53 from $56 at Cowen
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/16/22
- TJX sees Q4 revenue $13.9B-$14.1B, consensus $14.26B
- 11/16/22
- TJX lowers FY23 revenue view to $49.3B-$49.5B from $49.6B-$49.9B
- 11/16/22
- TJX cuts FY23 adjusted EPS view to $3.07-$3.11 from $3.13-$3.20, consensus $3.10
- 11/16/22
- TJX sees Q4 EPS 85c-89c, consensus 94c
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 09/08/22
- RH cuts FY22 revenue growth view to down 5.5% to down 3.5%
- 09/08/22
- RH reports Q2 EPS $8.08, consensus $6.81
- 06/29/22
- RH cuts FY22 revenue growth view to down 5% to down 2%
- 09/12/22
- Rent The Runway lowers FY23 revenue view to $285M-$290M from $295M-$305M
- 09/12/22
- Rent The Runway sees Q3 revenue $72M-$74M, consensus $79.72M
- 09/12/22
- Rent The Runway reports Q2 EPS (53c), consensus (65c)
- 06/09/22
- Rent The Runway sees FY22 revenue $ $295-$305M, consensus $303.87M
- 11/03/22
- Pinnacle West reports Q3 EPS $2.88, consensus $2.60
- 11/03/22
- Pinnacle West raises FY22 EPS view to $4.20-$4.35 from $3.90-$4.10
- 11/03/22
- Pinnacle West reports Q3 EPS $2.88, consensus $2.60
- 08/03/22
- Pinnacle West backs FY22 EPS view of $3.90-$4.10, consensus $4.02
- 10/27/22
- Merck raises FY22 adjusted EPS view to $7.32-$7.37 from $7.25-$7.35
- 10/27/22
- Merck reports Q3 adjusted EPS $1.85, consensus $1.71
- 10/26/22
- Notable companies reporting before tomorrow's open
- 10/27/22
- Insmed reports Q3 EPS ($1.09), consensus (89c)
- 08/04/22
- Insmed reports Q2 EPS (80c), consensus (89c)
- 08/30/22
- HP Inc. cuts FY22 EPS view to $4.02-$4.12 from $4.24-$4.38, consensus $4.30
- 08/30/22
- HP Inc. sees Q4 EPS 79c-89c, consensus $1.06
- 08/30/22
- HP Inc. reports Q3 EPS $1.04, consensus $1.04
- 08/30/22
- Notable companies reporting after market close
- 11/07/22
- Fulgent Genetics sees FY22 adjusted EPS $5.60, consensus $5.80
- 11/07/22
- Fulgent Genetics sees Q4 revenue roughly $60M, consensus $86.7M
- 11/07/22
- Fulgent Genetics reports Q3 adjusted EPS 32c, two estimates 5c
- 11/02/22
- Editas Medicine reports Q3 EPS (81c), consensus (86c)
- 08/03/22
- Editas Medicine reports Q2 EPS (78c), consensus (82c)
- 10/13/22
- Domino's Pizza reports Q3 EPS $2.79, consensus $2.97
- 07/21/22
- Domino's Pizza reports Q2 EPS $2.82, consensus $2.90
- 07/20/22
- Notable companies reporting before tomorrow's open
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 10/27/22
- Notable companies reporting after market close
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 11/17/22
- Applied Materials sees Q1 adjusted EPS $1.75-$2.11, consensus $1.83
- 11/17/22
- Applied Materials reports Q4 adjusted EPS $2.03, consensus $1.73
- 11/17/22
- Notable companies reporting after market close
- 10/12/22
- Applied Materials cuts Q4 adjusted EPS view to $1.54-$1.78 from $1.82-$2.18
WBA Walgreens Boots Alliance - 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 11/01/22
- Walgreens, Walmart, CVS reach $12B opioid settlement deal, Bloomberg reports
- 11/01/22
- Walgreens-backed VillageMD in talks to merge with Summit, Bloomberg reports
- 10/02/22
- Walgreens turns to prescription-filling robots to free up pharmacists, WSJ says
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 10/07/22
- Merck's Lagevrio sped COVID recovery, didn't lower hospital risk, STAT says
- 08/26/22
- Merck's Seagen bid hit snag over price concerns, Bloomberg reports
- 08/25/22
- Merck's bid for Seagen stalled on price concerns, Bloomberg reports
- 06/06/22
- CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports
- 10/18/22
- Editas in talks to sell preclinical oncology assets, Endpoints News says
- 07/25/22
- Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says
- 11/02/22
- New Ohio online sports betting operators approved, Saturday Tradition says
- 10/10/22
- DraftKings, others pull back on ads to legalize CA online sports betting, WSJ says
- 10/06/22
- DraftKings, ESPN near signing exclusive deal, Action Network reports
- 10/06/22
- ESPN, DraftKing close to large new partnership, Bloomberg reports
- 11/18/22
- Amazon layoffs to continue into 2023, CNBC reports
- 11/17/22
- Amazon offers some employees voluntary buyout program, CNBC reports
- 11/16/22
- AWS extends hiring halt for 'most' teams into 1Q23, Fortune says
- 11/16/22
- Amazon lays off some workers in devices business, Reuters reports
- 10/06/22
- U.S. to effectively halt some NAND, DRAM equipment export to China, Reuters says
- 07/27/22
- Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says
WBA Walgreens Boots Alliance - 11/14/22
- Here's what Wall Street experts are saying about Walmart ahead of earnings
- 11/11/22
- What You Missed On Wall Street On Friday
- 11/16/22
- What You Missed On Wall Street On Wednesday
- 11/16/22
- What You Missed On Wall Street This Morning
- 11/10/22
- What You Missed On Wall Street On Thursday
- 10/25/22
- What You Missed On Wall Street On Tuesday
- 09/09/22
- What You Missed On Wall Street On Friday
- 09/09/22
- What You Missed On Wall Street This Morning
- 09/08/22
- Fly Intel: After-Hours Movers
- 09/13/22
- What You Missed On Wall Street On Tuesday
- 09/13/22
- What You Missed On Wall Street This Morning
- 09/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/03/22
- What You Missed On Wall Street On Thursday
- 11/03/22
- What You Missed On Wall Street This Morning
- 10/27/22
- What You Missed On Wall Street On Thursday
- 10/27/22
- What You Missed On Wall Street This Morning
- 10/27/22
- Fly Intel: Pre-market Movers
- 11/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/18/22
- Fly Intel: Pre-market Movers
- 09/01/22
- What You Missed On Wall Street On Thursday
- 09/01/22
- What You Missed On Wall Street This Morning
- 11/07/22
- Fly Intel: After-Hours Movers
- 11/17/22
- What You Missed On Wall Street On Thursday
- 11/17/22
- What You Missed On Wall Street This Morning
- 10/13/22
- What You Missed On Wall Street This Morning
- 10/13/22
- Fly Intel: Pre-market Movers
- 11/11/22
- Bet On It: Propositions to legalize sports betting in California fall short
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/15/22
- Here's what Wall Street experts are saying about Target ahead of earnings
- 11/17/22
- Fly Intel: After-Hours Movers
- 10/13/22
- What You Missed On Wall Street On Thursday
WBA Walgreens Boots Alliance - 11/11/22
- Unusually active option classes on open November 11th
- 11/07/22
- Early notable gainers among liquid option names on November 7th
- 11/07/22
- Unusually active option classes on open November 7th
- 10/13/22
- Early notable gainers among liquid option names on October 13th
- 06/28/22
- TJX call volume above normal and directionally bullish
- 05/20/22
- TJX put volume heavy and directionally bearish
- 05/18/22
- Early notable gainers among liquid option names on May 18th
- 05/18/22
- Unusually active option classes on open May 18th
- 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
- 05/23/22
- Early notable gainers among liquid option names on May 23rd
- 05/19/22
- Ross Stores options imply 8.6% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
- 09/06/22
- Restoration Hardware call volume above normal and directionally bullish
- 07/18/22
- Restoration Hardware put volume heavy and directionally bearish
- 06/09/22
- Rent the Runway options imply 15.4% move in share price post-earnings
- 11/14/22
- Early notable gainers among liquid option names on November 14th
- 10/10/22
- Early notable gainers among liquid option names on October 10th
- 10/10/22
- Unusually active option classes on open October 10th
- 09/29/22
- Early notable gainers among liquid option names on September 29th
- 10/25/22
- HP Inc. put volume heavy and directionally bearish
- 08/30/22
- HP Inc. options imply 6.2% move in share price post-earnings
- 08/26/22
- Unusually active option classes on open August 26th
- 08/09/22
- HP Inc. put volume heavy and directionally bearish
- 10/03/22
- Domino's Pizza Inc call volume above normal and directionally bullish
- 09/23/22
- Early notable gainers among liquid option names on September 23rd
- 10/07/22
- Unusually active option classes on open October 7th
- 08/29/22
- Unusually active option classes on open August 29th
- 08/05/22
- Unusually active option classes on open August 5th
- 08/02/22
- Unusually active option classes on open August 2nd
- 11/18/22
- Notable open interest changes for November 18th
- 11/17/22
- Notable open interest changes for November 17th
- 11/16/22
- Notable open interest changes for November 16th
- 11/15/22
- Notable open interest changes for November 15th
- 11/17/22
- Applied Materials options imply 3.2% move in share price post-earnings
- 08/18/22
- Applied Materials options imply 3.8% move in share price post-earnings
- 07/26/22
- Applied Materials put volume heavy and directionally bearish
- 05/19/22
- Applied Materials options imply 6.3% move in share price post-earnings
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 09/14/22
- Williams-Sonoma names Jeff Howie as new CFO
- 09/13/22
- West Elm, office furniture startup Branch announce retail partnership
WBA Walgreens Boots Alliance - 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 11/02/22
- Walgreens Boots Alliance agrees to pay $4.95B to settle opioid claims
- 11/02/22
- Walgreens to pay about $5B to resolve some opioid lawsuits with states, tribes
- 11/02/22
- Western Union enters renewed five-year agreement with Walgreens
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/17/22
- Provention Bio trading resumes
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 11/17/22
- Provention Bio trading halted, news pending
- 10/06/22
- Provention Bio jumps 16% after announcing co-promotion pact with Sanofi US
- 11/17/22
- Palo Alto Networks CEO: We're taking a knife to our costs
- 11/17/22
- Palo Alto Networks jumps 5% after Q1 results, FY23 guidance beat estimates
- 11/17/22
- Palo Alto Networks confirms agreement to acquire Cider Security for $195M cash
- 11/17/22
- Palo Alto Networks announces receipt of initial $67M purchase order from DOD
- 11/16/22
- Else Nutrition launches on second online store, JD.com
- 08/23/22
- JD.com reports annual active customer accounts up 9.2% to 580.8M
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 06/29/22
- JD.com announces renewed strategic cooperation with Tencent
- 09/01/22
- Avid Technology to replace Plantronics in the S&P 600 at open on 9/1
- 08/30/22
- HP Inc. CEO: Supply chain situation is 'getting closer to normal'
- 08/29/22
- HP Inc. completes acquisition of Poly
- 11/02/22
- G1 Therapeutics reports data from first patients in Phase 2 study of trilaciclib
- 10/26/22
- G1 announces investigator-initiated study of trilaciclib, lurbinectedin
- 10/10/22
- G1 Therapeutics completes enrollment in Phase 3 clinical trial of trilaciclib
- 09/12/22
- Day One Biopharmaceuticals appoints Nicholson as chairman
- 11/18/22
- Foot Locker jumps 17% to $38.80 after Q3 results beat, FY22 guidance raised
- 11/17/22
- Foot Locker opens new distribution center in Nevada
- 11/14/22
- Foot Locker, PUMA expand partnership to reach next-generation customers
- 08/19/22
- Foot Locker rises 22.0%
- 11/18/22
- DraftKings to launch online sportsbook in Maryland on November 23
- 11/09/22
- DraftKings lower after California voters reject sports betting measures
- 11/04/22
- DraftKings CEO: Right in line on where we thought we'd be with user growth
- 10/27/22
- Nevada reports September statewide gaming win up 7.87% to $1.25B
- 06/22/22
- Atkore acquires United Poly Systems
- 05/20/22
- Atkore, Nextracker announce new manufacturing line in Arizona
- 05/19/22
- Atkore acquires Talon Products, terms not disclosed
- 11/17/22
- Ardelyx director Mott acquires 567,000 common shares
- 11/16/22
- Ardelyx trading resumes
- 11/16/22
- Ardelyx's Xphozah for kidney disease receives favorable FDA vote
- 11/16/22
- Nasdaq halts trading of Ardelyx common stock
- 11/16/22
- Wafer Fab Equipment names slide after Micron cuts wafer starts
- 10/24/22
- Applied Materials appoints March to board of directors
- 10/19/22
- Microvast, Albemarle among infrastructure law funding recipients
- 09/11/22
- Fly Intel: Top five weekend stock stories
- 10/06/22 Jefferies
- Provention Bio price target raised to $15 from $10 at Jefferies
- 10/06/22 Chardan
- Provention co-promotion deal reinforces Chardan's confidence in teplizumab
- 10/06/22 SVB Securities
- Provention Bio, Sanofi teplizumab partnership 'attractive,' says SVB Securities
- 09/20/22 Jefferies
- Provention Bio initiated with a Buy at Jefferies
- 11/17/22 Piper Sandler
- Ardelyx upgraded to Overweight from Neutral at Piper Sandler
- 08/18/22 Citi
- Ardelyx price target lowered to $10 from $12 at Citi
- 05/18/22 Piper Sandler
- Ardelyx price target lowered to $3 from $4 at Piper Sandler
- 05/06/22 Cantor Fitzgerald
- Ardelyx downgraded to Neutral from Overweight at Cantor Fitzgerald
WBA Walgreens Boots Alliance - 11/18/22 JPMorgan
- Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
- 11/11/22 Deutsche Bank
- Walgreens upgraded to Buy with $50 target at Deutsche Bank
- 11/11/22 Deutsche Bank
- Walgreens Boots Alliance upgraded to Buy from Hold at Deutsche Bank
- 11/08/22 Truist
- Walgreens Boots Alliance price target raised to $44 from $38 at Truist
- 11/18/22 Piper Sandler
- DraftKings initiated with an Overweight at Piper Sandler
- 11/07/22 Craig-Hallum
- DraftKings price target lowered to $21 from $30 at Craig-Hallum
- 11/07/22 Guggenheim
- DraftKings price target lowered to $27 from $31 at Guggenheim
- 11/07/22 Canaccord
- DraftKings price target lowered to $28 from $32 at Canaccord
- 11/14/22 Mizuho
- JD.com price target lowered to $82 from $90 at Mizuho
- 10/31/22 Morgan Stanley
- JD.com price target lowered to $55 from $80 at Morgan Stanley
- 10/28/22 Morgan Stanley
- JD.com named a 'Catalyst Driven Idea' at Morgan Stanley
- 10/28/22 Barclays
- JD.com price target lowered to $59 from $66 at Barclays
- 11/14/22 Deutsche Bank
- Foot Locker price target lowered to $31 from $34 at Deutsche Bank
- 11/11/22 Citi
- Citi cuts Foot Locker target, opens 'negative catalyst watch'
- 10/31/22 JPMorgan
- Foot Locker price target lowered to $37 from $40 at JPMorgan
- 08/23/22 Credit Suisse
- Foot Locker price target raised to $40 from $31 at Credit Suisse
- 11/18/22 Morgan Stanley
- Ross Stores assumed with an Overweight at Morgan Stanley
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/18/22 Baird
- Ross Stores price target raised to $125 from $105 at Baird
- 11/18/22 Morgan Stanley
- Palo Alto Networks 'ready to re-rate,' says Morgan Stanley
- 11/18/22 Deutsche Bank
- Palo Alto Networks price target raised to $217 from $209 at Deutsche Bank
- 11/18/22 Wolfe Research
- Palo Alto price target lowered to $225 from $238 at Wolfe Research
- 11/18/22 Barclays
- Palo Alto Networks price target raised to $215 from $200 at Barclays
- 10/18/22 Loop Capital
- Atkore initiated with a Buy at Loop Capital
- 10/10/22 Citi
- Atkore price target lowered to $94 from $97 at Citi
- 08/03/22 Credit Suisse
- Atkore price target raised to $143 from $130 at Credit Suisse
- 05/04/22 RBC Capital
- Atkore price target raised to $170 from $123 at RBC Capital
- 10/14/22 Tigress Financial
- Dolby price target lowered to $116 from $128 at Tigress Financial
- 06/08/22
- Baird to hold a conference
- 05/23/22 Rosenblatt
- Dolby initiated with a Buy at Rosenblatt
- 11/18/22 Wells Fargo
- Williams-Sonoma price target lowered to $120 from $170 at Wells Fargo
- 11/18/22 Cowen
- Williams-Sonoma price target lowered to $145 from $170 at Cowen
- 11/18/22 RBC Capital
- Williams-Sonoma price target lowered to $151 from $192 at RBC Capital
- 11/11/22 JPMorgan
- Williams-Sonoma price target lowered to $131 from $143 at JPMorgan
- 11/18/22 BofA
- HP Inc. price target lowered to $27 from $30 at BofA
- 11/18/22 Citi
- HP Inc. price target lowered to $31 from $33 at Citi
- 11/18/22 Credit Suisse
- HP Inc. downgraded to Neutral from Outperform at Credit Suisse
- 10/17/22 Morgan Stanley
- HP Inc. price target lowered to $24 from $28 at Morgan Stanley
- 11/02/22 H.C. Wainwright
- G1 Therapeutics price target lowered to $57 from $67 at H.C. Wainwright
- 09/16/22 Wedbush
- G1 Therapeutics price target raised to $25 from $20 at Wedbush
- 11/18/22 Evercore ISI
- Applied Materials price target raised to $120 from $100 at Evercore ISI
- 11/18/22 Needham
- Applied Materials price target raised to $120 from $90 at Needham
- 11/18/22 Craig-Hallum
- Applied Materials price target raised to $126 from $95 at Craig-Hallum
- 11/18/22 UBS
- Applied Materials price target raised to $98 from $90 at UBS
- 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 08/24/22
- Williams-Sonoma backs FY22 and long term guidance
- 08/24/22
- Williams-Sonoma reports Q2 EPS $3.87, consensus $3.54
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
- 11/03/22
- Provention Bio reports Q3 EPS (34c), consensus (42c)
- 08/04/22
- Provention Bio reports Q2 EPS (46c), consensus (50c)
- 11/17/22
- Palo Alto Networks sees FY23 adjusted EPS $3.37-$3.44, consensus $3.17
- 11/17/22
- Palo Alto Networks sees Q2 adjusted EPS 76c-78c, consensus 71c
- 11/17/22
- Palo Alto Networks reports Q1 adjusted EPS 83c, consensus 69c
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 08/23/22
- JD.com reports Q2 adjusted EPS 61c, consensus 40c
- 08/30/22
- HP Inc. cuts FY22 EPS view to $4.02-$4.12 from $4.24-$4.38, consensus $4.30
- 08/30/22
- HP Inc. sees Q4 EPS 79c-89c, consensus $1.06
- 08/30/22
- HP Inc. reports Q3 EPS $1.04, consensus $1.04
- 08/30/22
- Notable companies reporting after market close
- 11/02/22
- G1 Therapeutics reports Q3 EPS (59c), consensus (63c)
- 08/03/22
- G1 Therapeutics reports Q2 EPS (92c), consensus ($1.02)
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- 11/18/22
- Foot Locker sees Q4 EPS 45c-53c, consensus 43c
- 11/18/22
- Foot Locker reports Q3 EPS $1.27, consensus $1.11
- 11/17/22
- Notable companies reporting before tomorrow's open
- 11/17/22
- Dolby says FY23 revenue expected to grow low single digits year-over-year
- 11/17/22
- Dolby sees Q1 EPS 76c-91c, consensus $1.10
- 11/17/22
- Dolby reports Q4 EPS 54c, consensus 60c
- 08/09/22
- Dolby sees FY22 EPS $3.22-$3.37, consensus $3.39
- 11/17/22
- Delta Apparel reports Q4 EPS (4c) vs. 96c last year
- 11/04/22
- DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B
- 11/04/22
- DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B
- 11/04/22
- DraftKings reports Q3 revenue $502M, consensus $437.23M
- 11/03/22
- Notable companies reporting before tomorrow's open
- 11/18/22
- Atkore sets FY25 adjusted EPS target of greater than $18
- 11/18/22
- Atkore sees FY23 adjusted EPS $13.10-$14.90, consensus $13.31
- 11/18/22
- Atkore sees Q1 adjusted EPS $3.85-$4.20, consensus $2.53
- 11/18/22
- Atkore reports Q4 adjusted EPS $5.52, consensus $5.08
- 11/03/22
- Ardelyx reports Q3 EPS (14c), consensus (17c)
- 08/04/22
- Ardelyx reports Q2 EPS (19c), consensus (19c)
- 11/17/22
- Applied Materials sees Q1 adjusted EPS $1.75-$2.11, consensus $1.83
- 11/17/22
- Applied Materials reports Q4 adjusted EPS $2.03, consensus $1.73
- 10/12/22
- Applied Materials cuts Q4 adjusted EPS view to $1.54-$1.78 from $1.82-$2.18
|
Initiation
|
Morgan Stanley analyst… Morgan Stanley analyst Alex Straton assumed coverage of Ross Stores with an Overweight rating with a price target of $127, up from $119, following the company's Q3 report. The magnitude of the Q3 beat "surprised to the upside" and revenue re-acceleration "makes for a compelling set-up" into Q4 and 2023, said Straton, who thinks "things only get better from here." ShowHide Related Items >><< - 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 07/14/22
- Ross Stores extends employment contract of CMO Morrow through March 2026
- 11/18/22 Deutsche Bank
- Ross Stores price target raised to $121 from $99 at Deutsche Bank
- 11/18/22 JPMorgan
- Ross Stores price target raised to $121 from $112 at JPMorgan
- 11/18/22 Baird
- Ross Stores price target raised to $125 from $105 at Baird
- 11/18/22 Credit Suisse
- Ross Stores price target raised to $123 from $99 at Credit Suisse
- 11/17/22
- Ross Stores raises FY22 EPS view to $4.21-$4.34 from $3.84-$4.12
- 11/17/22
- Ross Stores sees Q4 EPS $1.13-$1.26, consensus $1.13
- 11/17/22
- Ross Stores reports Q3 EPS $1.00, consensus 81c
- 11/17/22
- Notable companies reporting after market close
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 05/21/22
- TJX among off-price retailers looking like bargains, Barron's says
- 11/17/22
- Fly Intel: After-Hours Movers
- 10/25/22
- What You Missed On Wall Street On Tuesday
- 10/25/22
- What You Missed On Wall Street This Morning
- 10/25/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Ross Stores options imply 4.9% move in share price post-earnings
- 08/18/22
- Ross Stores options imply 6.1% move in share price post-earnings
- 05/23/22
- Early notable gainers among liquid option names on May 23rd
- 05/19/22
- Ross Stores options imply 8.6% move in share price post-earnings
|